BR112023017666A2 - Métodos para controle de infestações de pulgas e carrapatos em mamíferos - Google Patents

Métodos para controle de infestações de pulgas e carrapatos em mamíferos

Info

Publication number
BR112023017666A2
BR112023017666A2 BR112023017666A BR112023017666A BR112023017666A2 BR 112023017666 A2 BR112023017666 A2 BR 112023017666A2 BR 112023017666 A BR112023017666 A BR 112023017666A BR 112023017666 A BR112023017666 A BR 112023017666A BR 112023017666 A2 BR112023017666 A2 BR 112023017666A2
Authority
BR
Brazil
Prior art keywords
mammal
flea
active material
tick
period
Prior art date
Application number
BR112023017666A
Other languages
English (en)
Portuguese (pt)
Inventor
R Winkle Joseph
E Willard Kevin
S Readnour Robin
Original Assignee
In The Bowl Animal Health Inc
R Winkle Joseph
E Willard Kevin
S Readnour Robin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by In The Bowl Animal Health Inc, R Winkle Joseph, E Willard Kevin, S Readnour Robin filed Critical In The Bowl Animal Health Inc
Publication of BR112023017666A2 publication Critical patent/BR112023017666A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/761,3-Oxazoles; Hydrogenated 1,3-oxazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P17/00Pest repellants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00Arthropodicides
    • A01P7/02Acaricides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00Arthropodicides
    • A01P7/04Insecticides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/132Heterocyclic compounds containing only one nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112023017666A 2021-03-11 2022-03-11 Métodos para controle de infestações de pulgas e carrapatos em mamíferos BR112023017666A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163159801P 2021-03-11 2021-03-11
PCT/US2022/019913 WO2022192648A1 (en) 2021-03-11 2022-03-11 Methods for controlling flea and tick infestations in a mammal

Publications (1)

Publication Number Publication Date
BR112023017666A2 true BR112023017666A2 (pt) 2023-11-14

Family

ID=83227137

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023017666A BR112023017666A2 (pt) 2021-03-11 2022-03-11 Métodos para controle de infestações de pulgas e carrapatos em mamíferos

Country Status (10)

Country Link
US (1) US20230413819A1 (https=)
EP (1) EP4304722A4 (https=)
JP (1) JP2024513690A (https=)
KR (1) KR20230161996A (https=)
CN (1) CN117500498A (https=)
AU (1) AU2022234415A1 (https=)
BR (1) BR112023017666A2 (https=)
CA (1) CA3211582A1 (https=)
MX (1) MX2023010380A (https=)
WO (1) WO2022192648A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122011100022I1 (de) * 1999-08-12 2011-10-20 Lilly Co Eli Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.
DE602004017347D1 (de) * 2003-11-04 2008-12-04 Intervet Int Bv Azol-pestiziden
UA108200C2 (uk) * 2009-05-08 2015-04-10 Лікарські форми та способи застосування ектопаразитоцидів
CA2764526A1 (en) * 2009-06-24 2010-12-29 Christine Kritikou The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
WO2012155352A1 (en) * 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
WO2020201440A1 (en) * 2019-04-03 2020-10-08 Virbac Low dose fluralaner compositions for protection against parasitic invertebrate pest

Also Published As

Publication number Publication date
CN117500498A (zh) 2024-02-02
WO2022192648A1 (en) 2022-09-15
KR20230161996A (ko) 2023-11-28
EP4304722A4 (en) 2025-01-22
US20230413819A1 (en) 2023-12-28
JP2024513690A (ja) 2024-03-27
EP4304722A1 (en) 2024-01-17
CA3211582A1 (en) 2022-09-15
MX2023010380A (es) 2024-01-24
AU2022234415A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
Henter et al. Glutamatergic modulators in depression
Menczel Schrire et al. Safety of higher doses of melatonin in adults: a systematic review and meta‐analysis
Kato et al. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: convergent mechanisms
Landen et al. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression
US10092564B2 (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
US20200323843A1 (en) Use of levocetirizine and montelukast in the treatment of viral infection caused by coronavirus
BR112020004947A2 (pt) canabidiol transdérmico sintético para o tratamento de epilepsia focal em adultos
Van Hiele l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with ‘therapy-resistant’depressions
US20190298677A1 (en) Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms
Zakaria et al. The potential role of melatonin on memory function: lessons from rodent studies
CN104039148A (zh) 组合als疗法
BR112020013750A8 (pt) Dispensação intranasal de olanzapina por dispositivo olfativo de precisão
BR112023017666A2 (pt) Métodos para controle de infestações de pulgas e carrapatos em mamíferos
JP2006508118A5 (https=)
Dekkers et al. An acute oral intoxication with haloperidol decanoate
MX2024008330A (es) Combinacion de obicetrapib e inhibidor de sglt2
Saurat et al. Arotinoid acid (Ro 13-7410): a pilot study in dermatology
CN114903840A (zh) 一种治疗抑郁症的低剂量r-氯胺酮经鼻药物
CN110327321B (zh) 对饮酒导致中枢神经突触可塑性改变具有解救作用氨基酸在制备治疗酒精成瘾的药物中的应用
WO2021205402A1 (en) Endoxifen for the treatment of bipolar i disorder
CL2023003153A1 (es) Régimen de dosificación universal de 25-hidroxivitamina d3
RU2828854C1 (ru) Способ лечения коронавирусной инфекции, гриппа
JP2004525977A (ja) 酸化ストレスの改善を目的とするクレアチンの使用
US20250360215A1 (en) Pharmaceutical combinations and methods for preventing or treating neurodegenerative diseases
RU2746295C1 (ru) Способ обезболивания и седации в стоматологии